4.4 Article

Ultra-High-Dose-Rate FLASH Irradiation Limits Reactive Gliosis in the Brain

期刊

RADIATION RESEARCH
卷 194, 期 6, 页码 636-645

出版社

RADIATION RESEARCH SOC
DOI: 10.1667/RADE-20-00067.1

关键词

-

资金

  1. UCI School of Medicine Faculty Pilot Research Award [19900]
  2. University of California Cancer Research Coordinating Committee award [CRR-19-585293]
  3. Health and Environmental Sciences Institute (HESI-Thrive award)
  4. ISREC Foundation
  5. Synergia [FNS CRS II5_186369]
  6. National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH) (NINDS) [NS089575]
  7. National Cancer Institute, NIH [NCI] [P01CA244091]
  8. Ecole Normale Supe' rieure de Cachan fellowship (MESR)
  9. Biltema
  10. FNS [31003A_156892]
  11. Swiss National Science Foundation (SNF) [31003A_156892] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Encephalic radiation therapy delivered at a conventional dose rate (CONV, 0.1-2.0 Gy/min) elicits a variety of temporally distinct damage signatures that invariably involve persistent indications of neuroinflammation. Past work has shown an involvement of both the innate and adaptive immune systems in modulating the central nervous system (CNS) radiation injury response, where elevations in astrogliosis, microgliosis and cytokine signaling define a complex pattern of normal tissue toxicitics that never completely resolve. These side effects constitute a major limitation in the management of CNS malignancies in both adult and pediatric patients. The advent of a novel ultra-high dose-rate irradiation modality termed FLASH radiotherapy (FLASH-RT, instantaneous dose rates >10(6) Gy/s; 10 Gy delivered in 1-10 pulses of 1.8 mu s) has been reported to minimize a range of normal tissue toxicities typically concurrent with CONV exposures, an effect that has been coined the FIASH effect. Since the FLASH effect has now been found to significantly limit persistent inflammatory signatures in the brain, we sought to further elucidate whether changes in astrogliosis might account for the differential dose-rate response of the irradiated brain. Here we report that markers selected for activated astrogliosis and immune signaling in the brain (glial fibrillary acidic protein, GFAP; toll-like receptor 4, TLR4) are expressed at reduced levels after FLASH irradiation compared to CONV-irradiated animals. Interestingly, while FLASH-RT did not induce astrogliosis and TLR4, the expression level of complement Clq and C3 were found to be elevated in both FLASH and CONV irradiation modalities compared to the control. Although functional outcomes in the CNS remain to be cross-validated in response to the specific changes in protein expression reported, the data provide compelling evidence that distinguishes the dose-rate response of normal tissue injury in the irradiated brain. (C) 2020 by Radiation Research Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据